Russell Investments Group’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$341K Buy
17,986
+1,020
+6% +$16.5K ﹤0.01% 2655
2025
Q4
$297K Sell
16,966
-41,133
-71% -$774K ﹤0.01% 2686
2025
Q3
$1.2M Sell
58,099
-145,779
-72% -$3.54M ﹤0.01% 2132
2025
Q2
$4.34M Sell
203,878
-7,126
-3% -$163K 0.01% 1303
2025
Q1
$4.07M Buy
211,004
+141,664
+204% +$2.84M 0.01% 1275
2024
Q4
$1.24M Sell
69,340
-20,801
-23% -$403K ﹤0.01% 1906
2024
Q3
$1.97M Buy
90,141
+83,085
+1,178% +$1.16M ﹤0.01% 1693
2024
Q2
$55K Buy
7,056
+960
+16% +$5.18K ﹤0.01% 2742
2024
Q1
$25.2K Buy
6,096
+3,579
+142% +$14.2K ﹤0.01% 2746
2023
Q4
$6.57K Hold
2,517
﹤0.01% 2873
2023
Q3
$4.71K Buy
+2,517
New +$4.8K ﹤0.01% 3154
2022
Q1
Sell
-216,991
Closed -$582K 2915
2021
Q4
$582K Buy
216,991
+129,578
+148% +$623K ﹤0.01% 2388
2021
Q3
$437K Buy
+87,413
New +$627K ﹤0.01% 2522

Other funds holding SMMT